Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME
Fitchett D, Zinman B, Wanner C, et al. European Heart Journal. First pub. online: 26 January 2016 http://eurheartj.oxfordjournals.org/content/early/2016/01/26/eurheartj.ehv728.abstract?papetoc
Leggi


